ArticleTherapeutic advances in medical oncology2024

CD34 as a potential prognostic indicator for camrelizumab response in advanced non-small-cell lung cancer: insights from digital spatial profiling.

Xinyi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.